(Hypertension. 1995;25:110-116.)
© 1995 American Heart Association, Inc.
Articles |
From the Hypertension and Vascular Research Laboratories, Department of Internal Medicine, University of Texas Medical Branch, Galveston Island.
Correspondence to Richard Bukoski, PhD, Hypertension and Vascular Research Laboratories, J-65, University of Texas Medical Branch, Galveston Island, TX 77550.
| Abstract |
|---|
|
|
|---|
Key Words: hypertension, genetic muscle, smooth, vascular fura 2 calcium vascular resistance
| Introduction |
|---|
|
|
|---|
In contrast with these reports, our laboratory has found that basal levels of intracellular Ca2+ are not elevated in intact mesenteric resistance arteries of SHR compared with those of Wistar-Kyoto (WKY) rats23 and that the force and intracellular Ca2+ responses of resistance arteries to maximal activation with 100 mmol/L K+ and 10 µmol/L norepinephrine are similar in vessels of the two strains.24 Given the fact that our previous results do not support the widely held hypothesis that vascular Ca2+ metabolism is deranged in vascular smooth muscle of genetically hypertensive animals, we have performed additional experiments to test two key hypotheses. One states that intracellular Ca2+ mobilization is heightened in mesenteric resistance arteries of SHR compared with vessels of normotensive WKY and Wistar rats. The second states that myofilament Ca2+ sensitivity is greater in vessels of SHR compared with those of the normotensive strains.
| Methods |
|---|
|
|
|---|
Simultaneous Measurement of Force and Ca2+
Intracellular Ca2+ and stress development
were determined as described.31 A modification that was
introduced was the use of a bicarbonate-buffered salt solution (PSS) of
the following composition (mmol/L): NaCl 130, KCl 4.7,
MgSO47H2O 1.17, glucose 5, CaCl2
1.50, and NaHCO3 15, at pH 7.4, which was gassed with 95%
air/5% CO2 in place of the nongassed HEPES-buffered
solution that was used in the original report.31 In
addition, the illumination system was converted from a transmission
fluorescence to an epifluorescence arrangement, which increased the
signal-to-noise ratio from 0.2 to 2.0. The myograph was placed on the
stage of an inverted microscope interfaced with a dual excitation
wavelength fluorometer (SPEX-AR/CM) by means of a liquid light guide.
Fluorescent light was focused on the vessels by means of a x20 fluor
objective (Nikon). Emitted light was filtered with a 510-nm barrier
filter (Nikon BA-510) and detected with a photomultiplier tube. Data
were stored and analyzed on a personal computer.
Tissue loading with and calibration of fura 2 was performed as follows. Basal fluorescence of the vessel at 340, 360, and 380 nm was determined, followed by addition of 3 µmol/L fura 2-AM (Molecular Probes) dissolved in dimethyl sulfoxide and pluronic F-12. After incubation for 1 hour at 37°C, the vessel was washed five times with fresh PSS, and vessel fluorescence at 360 nm was redetermined to assess the extent of loading with fura 2. After the experimental protocol (see below), Ca2+-sensitive fura 2 in the vessel segments was calibrated by the sequential addition of 20 mmol/L ionomycin to determine R'max, 20 mmol/L EGTA (buffered to pH 7.4 with Tris-HCl) to determine R'min, and 10 mmol/L MnCl2 in Ca2+-free PSS to quench fura 2 fluorescence. For each vessel, baseline fluorescence was subtracted from all data points, and the Ca2+ concentration at a given time point was estimated using the experimentally derived parameters R'max, R'min, and ß' as previously described,32 where R'max and R'min are the ratios of fluorescence (340/380 nm) in the presence of saturating Ca2+ (R'max) and in the absence of Ca2+ (<15 nmol/L, R'min), and ß' is the ratio of fluorescence at 380 nm in the absence and presence of Ca2+.
The dissociation constant used was empirically determined in a separate series of experiments. For each determination, vessel segments were dissected from the mesentery of an individual rat and pooled. The pooled segments, with a wet weight of approximately 3 mg, were loaded with fura 2 as described above and then washed and placed in a solution of the following composition: 100 mmol/L KCl, 15 mmol/L NaCl, 50 mmol/L Tris-HCl at pH 7.2, and 1 µg/mL digitonin. The vessels were then pelleted, and the supernatant was transferred to a stainless steel chamber with a volume of 250 µL that was fitted with a glass coverslip and maintained at 37°C. The fluorescence of the captured dye (excitation, 340 and 380 nm; emission, 510 nm) in response to varying levels of free ionized Ca2+ was then determined in an EGTA (10 mmol/L) clamped solution. The free Ca2+ in this solution was verified using a Ca2+-specific electrode. Kd values were then calculated from Hill plots of log(F-Fmin/Fmax-F) versus log[Ca2+].33 The estimated values were not significantly different from one another (SHR, 235±18 nmol/L; WKY, 228±34 nmol/L; Wistar, 230±11 nmol/L; n=7-8; P=NS). We therefore ruled out the possibility that differential hydrolysis of fura 2-AM by vascular tissue of the three strains resulted in a species of the dye with an altered affinity for Ca2+.
Two different approaches for assessment of the Ca2+-force relation were taken. The first assessed the Ca2+-force relation after depletion of releasable stores of Ca2+. Baseline fluorescence was determined to provide an estimate of basal free intracellular Ca2+, after which the vessels were contracted once with a mixture of 100 mmol/L K+ and 10 µmol/L norepinephrine. Intracellular Ca2+ stores were then depleted by repeatedly inducing contraction with 10 µmol/L norepinephrine in nominally Ca2+-free medium until no contractile responses were observed. The segments were then exposed to either 100 mmol/L K+ plus 1 µmol/L phentolamine or 10 µmol/L norepinephrine. Ca2+ was then cumulatively added back to the bath, and the intracellular Ca2+ and force responses were recorded. ED25 and ED50 values for Ca2+ were determined by plotting, for each level of extracellular Ca2+ that was examined, percent maximal force response versus the level of intracellular Ca2+ achieved. The second method for assessing the Ca2+-force relation consisted of determining the intracellular Ca2+ and force responses to the cumulative addition of norepinephrine in the presence of constant, 1.5 mmol/L, extracellular Ca2+.
Data Analysis
Results were analyzed for between-strain differences using
either the Student's t test when single values between two
strains were compared or ANOVA with a repeated-measures design and
linear contrast analysis for comparisons between pairs of means
(SYSTAT). A value of P
.05 was assumed to indicate a
significant difference.
| Results |
|---|
|
|
|---|
|
Fura 2 was calibrated using an in situ method for each vessel studied. No between-strain differences were detected for R'max and ß', whereas the R'min value was slightly but significantly elevated in vessels of SHR compared with those of WKY and Wistar rats (Table 2). We also performed a separate series of experiments to empirically determine the Kd value for Ca2+ of fura 2 that had been hydrolyzed by and subsequently extracted from vessels of each strain (Table 2). The basal level of free intracellular Ca2+ was estimated using these derived calibration constants, and no between-strain differences were detected (Table 2).
|
The Ca2+-force relation was assessed by monitoring changes in intracellular Ca2+ and force during the cumulative addition of extracellular Ca2+ to Ca2+-depleted vessels in the presence of either 100 mmol/L K+ (plus phentolamine) or 10 µmol/L norepinephrine. Fig 1, left, shows a representative trace of the force and intracellular Ca2+ responses of a normotensive vessel in the presence of 10 µmol/L norepinephrine. Two aspects of the responses should be noted. One is that there is a dose-dependent increase in force and intracellular Ca2+ in response to extracellular Ca2+ up to 0.8 mmol/L. The second is that higher levels of extracellular Ca2+ induce relaxation of the segments and a fall in intracellular Ca2+. This relaxation was observed in vessels from all three strains when activated with 10 µmol/L norepinephrine but not with K+.
|
A maneuver used for assessment of the myofilament Ca2+ sensitivity was depletion of releasable intracellular Ca2+ pools by repeatedly (two to three times) inducing contraction with 10 µmol/L norepinephrine in the presence of nominally Ca2+-free PSS. This procedure resulted in a fall in the basal level of intracellular Ca2+ (Table 3). As noted above, basal Ca2+ in the subset of vessels that underwent Ca2+ depletion was similar among the three strains (Table 3). Depletion of releasable Ca2+ pools resulted in a significant fall in intracellular Ca2+ in vessels of all three strains, although the magnitude of the fall was significantly greater in SHR and Wistar rats compared with WKY rats. It thus appears that basal Ca2+ and the change in Ca2+ wrought by Ca2+ depletion are unrelated to blood pressure of the animal.
|
When the intracellular Ca2+ and force responses to
the cumulative addition of Ca2+ in the presence of
100 mmol/L K+ plus 1 µmol/L phentolamine were examined,
no strain differences in the active stress response (Fig 2, top) were detected. Because there was a trend for a
difference at higher concentrations of extracellular
Ca2+, we carried out a power analysis to
determine the fail-safe N value for rejecting the null hypothesis. The
analysis (power=0.80,
level=0.05) indicated that a total of 33
separate observations in each group would be needed to demonstrate a
significant difference. Moreover, no difference in the amount of
Ca2+ mobilized was detected (Fig 2, bottom). The
plots of percent tension versus the steady-state concentration of
intracellular Ca2+ that was achieved were not
different between vessels of the two strains (Fig 3). As
predicted from Fig 3, there was no strain difference in myofilament
Ca2+ sensitivity (ED25, 111±6.9
versus 117±8.2 nmol/L, SHR versus WKY; ED50,
144±10.2 versus 140±10.5 nmol/L, SHR versus WKY; n=10 and 11,
respectively; P=NS).
|
|
When the Ca2+ and force responses to cumulative addition of Ca2+ in the presence of 10 µmol/L norepinephrine were determined, there was a significant increase in the magnitude of active stress developed in response to the low doses of Ca2+ (0.025 to 0.1 mmol/L) in resistance arteries of SHR compared with vessels of WKY and Wistar rats (Fig 4, top). No difference in the intracellular Ca2+ response to addition of extracellular Ca2+ through 0.8 mmol/L was detected between SHR and WKY vessels, whereas intracellular Ca2+ was significantly attenuated in Wistar vessels in response to low levels of extracellular Ca2+ (Fig 4, bottom). The intracellular Ca2+ concentration achieved in response to 1.6 and 2.5 mmol/L extracellular Ca2+ was depressed in WKY compared with SHR vessels. Plots of percent tension versus the absolute level of free intracellular Ca2+ shown in Fig 5 indicate that myofilament Ca2+ sensitivity, as reflected by calculated ED25 values, is increased in resistance arteries of SHR (P<.05) compared with those of both normotensive strains. ED25 values for Ca2+ were 74.4±5.1 nmol/L for SHR (n=15), 89.8±5.5 nmol/L for WKY rats (n=12), and 86.9±3.4 nmol/L for Wistar rats (n=24). Moreover, ED50 values of SHR were significantly different from those of Wistar (P<.05) but not WKY rats (SHR, 97.3±6.2 nmol/L; WKY, 106±5.6 nmol/L; Wistar, 111.8±3.9 nmol/L).
|
|
Because we noted the differential force response of SHR and normotensive vessels to extracellular Ca2+ in the presence of 10 µmol/L norepinephrine, we also assessed the active stress and intracellular Ca2+ responses of SHR and WKY vessels to cumulative addition of norepinephrine in constant extracellular Ca2+. Fig 1, right, illustrates the active stress intracellular Ca2+ and force responses of a vessel isolated from a Wistar rat to cumulative addition of norepinephrine. Two aspects of this response should be noted. One is the graded increase in intracellular Ca2+ in response to the cumulative doses of norepinephrine; the second is the fact that at lower norepinephrine concentrations, there is no spike or overshoot in the intracellular Ca2+ response, whereas at 3 µmol/L norepinephrine and higher, the intracellular Ca2+ response is characterized by a peak followed by a plateau response to a lower but steady-state level.
Fig 6, top, illustrates the active stress response to cumulative addition of norepinephrine. No differences between SHR and WKY rats were detected. Moreover, no differences in steady-state concentrations of intracellular Ca2+ were detected between the strains (Fig 6, bottom). The Ca2+-force relations were similar between the two strains (Fig 7), as evidenced by similar ED50 values for Ca2+ (188±13 versus 171±12 mmol/L, SHR versus WKY; n=10 and 11, respectively; P=NS).
|
|
| Discussion |
|---|
|
|
|---|
A large body of experimental evidence demonstrates that resting levels of free intracellular platelet Ca2+ are elevated in platelets of hypertensive humans and SHR.16 17 18 19 20 21 22 As noted above, these results have been interpreted to indicate that free intracellular Ca2+ is also elevated in vascular smooth muscle. However, the results of the present study indicate that basal intracellular Ca2+ is not elevated in mesenteric resistance arteries of SHR compared with those of either WKY or Wistar rats and thus are inconsistent with the premise that basal Ca2+ is elevated in vascular smooth muscle of the SHR compared with normotensive strains.
The results obtained with vessels of SHR and WKY rats and now Wistar rats confirm and extend our earlier reports that intracellular Ca2+ does not differ between primary and first-passage cultures of mesenteric artery myocytes of SHR and WKY rats23 and intact vessel segments of these strains.24 These results do contrast with reports that basal and stimulated Ca2+ levels are elevated in cultured aortic myocytes13 14 15 and in intact aortic rings of SHR compared with WKY rats.34 It is not known why intracellular Ca2+ may be elevated in aorta of SHR and not in the mesenteric bed. Aside from potential methodological differences, it is important to remember that the aorta is a conduit vessel that does not significantly contribute to peripheral resistance. Thus, the data obtained in the present study using resistance arteries may be more directly relevant to questions regarding the potential contribution of altered vascular Ca2+ handling to the SHR model of hypertension. In addition to basal Ca2+, we have also found that Ca2+ mobilization in response to graded increases in norepinephrine was not different in the resistance arteries of SHR and WKY rats (Fig 4, bottom). This indicates that alterations in agonist-induced Ca2+ mobilization are not associated with elevated blood pressure in this model.
The results summarized in Table 3 are of interest because they show that depletion of the releasable Ca2+ pool results in a decrease in the resting level of free intracellular Ca2+ in all of the vessels studied. It is possible that the magnitude of the fall in intracellular Ca2+ induced by Ca2+ depletion reflects the size of the releasable pool of Ca2+; ie, a greater decrease in Ca2+ could reflect a larger releasable pool. Although the magnitude of the fall in Ca2+ induced by Ca2+ depletion is greater in SHR than WKY rats, it was not different between SHR and Wistar rats, indicating that the size of the releasable pool of Ca2+ is unrelated to blood pressure.
Although these data indicate a dissociation between Ca2+ handling and blood pressure, this interpretation must be accepted with caution. For instance, all of the measurements depend on accurate calibration of the hydrolyzed fura 2. As noted in "Methods," we used an in situ approach to determine calibration constants for fura 2 on a vessel-by-vessel basis and used a novel approach to rescue hydrolyzed fura 2 from vessels of each strain and empirically determine the dissociation constant (Kd) of fura 2 for Ca2+. We have therefore ruled out the possibility that differential hydrolysis of fura 2-AM by vascular smooth muscle of the three strains results in a species of fura 2 with altered affinities for Ca2+. The possibility does remain, however, that differences in the intracellular milieu of vascular myocytes of the three strains could contribute to altered fluorescence properties that remain unidentified. Thus, short of making simultaneous measurements of intracellular Ca2+ using the fluorescent indicator and a Ca2+-selective electrode as recently described by Jensen and colleagues,35 we believe that we have made a concerted effort to be accurate in our estimation of Ca2+ concentration.
Nonetheless, it remains possible that factors outside the realm of calibration may have affected the results. For example, it is possible that microcompartmentalization of Ca2+ pools exists within the cell and that these compartments cannot be distinguished with our signal-averaging approach. In addition, it is possible that influx of the cation into the cell is elevated in SHR but that sequestration and extrusion processes effectively remove it, having no net effect on cytosolic Ca2+ but resulting in greater turnover. Although such a phenomenon has been described in platelets,36 the effect of altered Ca2+ turnover within the cell on stability of the Ca2+-calmodulin complex and its ability to activate myosin light chain kinase and initiate force generation are not understood.
Another important aspect of this report is the result of our assessment of myofilament Ca2+ sensitivity. We found no differences in myofilament Ca2+ sensitivity of SHR and WKY vessels during activation with 100 mmol/L K+. In contrast, we found that the ED25 value for Ca2+ was greater in SHR vessels than in segments from both WKY and Wistar rats. These results indicate that myofilament Ca2+ sensitivity is enhanced in mesenteric resistance arteries of SHR compared with normotensive vessels. This observation agrees with the recent report of Soloviev and Bershtein,8 who examined Ca2+ sensitivity in saponin-skinned aorta of SHR and WKY rats, and earlier reports from Mulvany and Nyborg,9 which showed that the force response to extracellular Ca2+ is enhanced in SHR compared with WKY rats. It should be noted, however, that in contrast with the present report, neither of these studies included measurements of free intracellular Ca2+.
A concern that we had with our measurements was the possibility that the maneuver used to deplete releasable Ca2+ was nonphysiological and could complicate interpretation of the results. For example, it has been shown in white cells that Ca2+ depletion enhances flux of extracellular Ca2+ into the cell by causing the release of a soluble messenger.37 To assess this further, we determined myofilament Ca2+ sensitivity of SHR and WKY vessels during cumulative addition of norepinephrine in the presence of a constant level of extracellular Ca2+ (1.50 mmol/L) and found no difference in myofilament Ca2+ sensitivity. We have concluded that the difference in myofilament Ca2+ sensitivity of SHR versus WKY and Wistar vessels observed during cumulative addition of extracellular Ca2+ is real but requires nonphysiological manipulation to be detectable. Its contribution to the physiological state is therefore questionable.
A final point to address is the finding that there was a large difference in the apparent myofilament Ca2+ sensitivity depending on which measurement approach was used. When the Ca2+-force relation was determined during cumulative addition of extracellular Ca2+ to the norepinephrine-activated preparation, myofilament Ca2+ sensitivity was in the range of 70 to 80 nmol/L, whereas when it was assessed during cumulative addition of norepinephrine in the presence of constant extracellular Ca2+, the value was on the order of 180 nmol/L. We suspect that the lower ED50 values obtained with the first method are the result of constant exposure to the high level of norepinephrine, which could be expected to fully activate G proteinlinked pathways that enhance myofilament Ca2+ sensitivity,38 39 whereas the higher value is the result of combined graded increases in activation of the coupling pathways and intracellular Ca2+. The precise mechanisms involved warrant further investigation.
In conclusion, the results of the present studies have important implications for the proposed role of altered cellular Ca2+ handling metabolism as a causal factor in genetic hypertension. If Ca2+ is not elevated in vascular smooth muscle of the mesenteric bed yet resistance in this bed is elevated in the intact animal, one is led to conclude that disturbed vascular Ca2+ metabolism does not play a role in maintaining elevated peripheral resistance. Our data therefore support the growing sentiment that in genetic hypertension, structural changes, which are the result of vascular hypertrophy or remodeling, may play a larger role in maintaining elevated peripheral resistance than do changes in vascular reactivity.40
| Acknowledgments |
|---|
Received January 31, 1994; first decision March 9, 1994; accepted September 8, 1994.
| References |
|---|
|
|
|---|
2.
Remboldt CM, Murphy RA. Myoplasmic
[Ca2+] determines phosphorylation in
agonist-stimulated swine arterial muscle. Circ
Res. 1988;63:593-603.
3. Morgan KG. Calcium and vascular smooth muscle tone. Am Med J. 1987;82:9-15. [Medline] [Order article via Infotrieve]
4.
Bukoski RD, Kremer D. Vascular actions of the calciotropic
hormones. Am J Clin Nutr. 1991;54:220S-226S.
5.
Cohen ML, Berkowitz B. Decreased vascular relaxation in
hypertension. J Pharmacol Exp Ther. 1976;196:396-406.
6.
Holloway ET, Bohr DF. Reactivity of vascular smooth muscle in
hypertensive rats. Circ Res. 1973;33:678-685.
7. Boonen HCM, De Mey JGR. Increased calcium sensitivity in isolated resistance arteries from spontaneously hypertensive rats: effects of dihydropyridines. Eur J Pharmacol. 1990;179:403-412. [Medline] [Order article via Infotrieve]
8. Soloviev AI, Bershtein SA. The contractile apparatus in vascular smooth muscle cells of spontaneously hypertensive rats possess increased calcium sensitivity: the possible role of protein kinase C. J Hypertens. 1992;10:131-136. [Medline] [Order article via Infotrieve]
9. Mulvany MJ, Nyborg N. An increased calcium sensitivity of mesenteric resistance vessels in young and adult spontaneously hypertensive rats. Br J Pharmacol. 1980;71:585-596. [Medline] [Order article via Infotrieve]
10. Kwan CY, Belbeck L, Daniel EE. Abnormal biochemistry of vascular smooth muscle plasma membrane isolated from hypertensive rats. Mol Pharmacol. 1980;77:137-140.
11. Shibata S, Kochii M, Taniguchi T. Calcium fluxes and binding in the aortic smooth muscle from the spontaneously hypertensive rat. Blood Vessels. 1975;12:279-289. [Medline] [Order article via Infotrieve]
12. Webb RC, Bhalla RC. Altered calcium sequestration by subcellular fractions of vascular smooth muscle from spontaneously hypertensive rats. J Mol Cell Cardiol. 1976;8:651-661. [Medline] [Order article via Infotrieve]
13. Nabika T, Velletri PA, Beaven MA, Endo J, Lovenberg W. Vasopressin-induced calcium increases in smooth muscle cells from spontaneously hypertensive rats. Life Sci. 1985;37:579-584. [Medline] [Order article via Infotrieve]
14. Sugiyama T, Yoshizumi M, Takaku F, Urabe H, Tsukakoshi M, Kasuya T, Yazaki Y. The elevation of the cytoplasmic calcium ions in vascular smooth muscle cells in SHR: measurement of the free calcium ions in living cells by laser microspectrofluorometry. Biochem Biophys Res Commun. 1986;141:340-345. [Medline] [Order article via Infotrieve]
15. Sugiyama T, Yoshizumi M, Takaku F, Yazaki Y. Abnormal calcium handling in vascular smooth muscle cells of spontaneously hypertensive rats. J Hypertens. 1990;8:369-375. [Medline] [Order article via Infotrieve]
16. Erne P, Bolli P, Burgisser E, Buhler FR. Correlation of platelet calcium with blood pressure: effect of antihypertensive therapy. N Engl J Med. 1984;310:1084-1088. [Abstract]
17. Bruschi G, Bruschi ME, Caroppo M, Orlandini G, Spaggiari M, Cavatorta A. Cytoplasmic free [Ca2+] is increased in the platelets of spontaneously hypertensive rats and essential hypertensive patients. Clin Sci. 1985;68:179-184. [Medline] [Order article via Infotrieve]
18. Zimlichman R, Goldstein DS, Zimlichman S, Keiser HR. Cytosolic calcium in platelets of spontaneously hypertensive rats. J Hypertens. 1986;4:283-287. [Medline] [Order article via Infotrieve]
19. Lindner A, Kenny M, Meacham AJ. Effects of a circulating factor in patients with essential hypertension on intracellular free calcium in normal platelets. N Engl J Med. 1987;316:1084-1088. [Medline] [Order article via Infotrieve]
20.
Oshima T, Young EW, Bukoski RD, McCarron DA. Abnormal calcium
handling by fura-2 loaded platelets of spontaneously hypertensive rats.
Hypertension. 1990;15:606-611.
21.
Brickman A, Nyby MD, von Hungen K, Eggena P, Tuck ML.
Calciotropic hormones, platelet calcium, and blood pressure in
essential hypertension. Hypertension. 1990;16:515-522.
22.
Oshima T, Young EW, Bukoski RD, McCarron DA. The rise and
recovery of platelet Ca2+ evoked by thrombin and
ionomycin in spontaneously hypertensive rats.
Hypertension. 1991;18:758-762.
23. Bukoski RD. Intracellular free Ca2+ in mesenteric resistance arteries and primary cultured myocytes of the spontaneously hypertensive and normotensive rat. J Hypertens. 1990;8:37-43. [Medline] [Order article via Infotrieve]
24. Bukoski RD, Lastelic BA, Xue H, Li J, Bian K. Intracellular Ca2+ and force generation determined in resistance arteries of normotensive and hypertensive rats. J Hypertens. 1994;12:15-21. [Medline] [Order article via Infotrieve]
25. Osol G, Cipolla M, Knutson S. A new method for mechanically denuding the endothelium of small (50-150 microns) arteries with a human hair. Blood Vessels. 1989;26:320-324. [Medline] [Order article via Infotrieve]
26.
Andriantsitohaina R, Stoclet JC, Bukoski RD. Role of
endothelium on the effects of neuropeptide Y in mesenteric resistance
arteries of spontaneously hypertensive and Wistar-Kyoto normotensive
rats. J Pharmacol Exp Ther. 1991;257:276-281.
27.
Li J, Bukoski RD. Altered
endothelium-dependent relaxation of resistance arteries
of hypertensive and normotensive rats is a function of the contractile
agonist. Circ Res. 1993;72:290-296.
28. Li J, Ehrenfried L, Bukoski RD. Physiological changes in extracellular Ca2+ modulate endothelium-dependent reactivity of resistance arteries of spontaneously hypertensive and normotensive rats. Clin Exp Hypertens. 1993;15:849-866.
29.
Bukoski RD, Wagman DW, Wang D. Injection of 1,25 vitamin D
enhances resistance artery contractile properties.
Hypertension. 1990;16:523-531.
30. Bukoski RD, McCarron DA. Altered aortic reactivity and lowered blood pressure associated with high Ca2+-intake in the SHR. Am J Physiol. 1986;251:H976-H983.
31.
Bukoski RD, Bergmann C, Stoclet JC. Simultaneous measurement
of contractile force and intracellular Ca2+ in
isolated resistance arteries. Am J Physiol. 1989;257:H1728-H1735.
32.
Scanlon M, Williams DA, Fay FS. A
Ca2+-insensitive form of fura-2 associated with
polymorphonuclear leukocytes: assessment and accurate
Ca2+ measurement. J Biol Chem. 1987;262:6308-6312.
33.
Grynkiewicz G, Poenie M, Tsien RY. A new generation of
Ca2+ indicators with greatly improved fluorescence
properties. J Biol Chem. 1985;260:3440-3449.
34.
Sada T, Koike H, Ikeda M, Sato K, Ozaki H, Karaki H. Cytosolic
free calcium of aorta in hypertensive rats: chronic inhibition of
angiotensin converting enzyme. Hypertension. 1990;16:245-251.
35.
Jensen PE, Mulvany MJ, Aalkjaer C, Nilsson H, Yamaguchi
H. Free cytosolic Ca2+ measured with
Ca2+-selective electrodes and fura-2 in rat
mesenteric resistance arteries. Am J Physiol. 1993;265:H741-H746.
36.
Kimura M, Lasker N, Aviv A. Thapsigargin-evoked changes in
human platelet Ca, Na, pH and membrane potential. J Physiol
(Lond). 1993;464:1-13.
37. Randriamampita C, Tsien RY. Emptying of intracellular Ca2+ stores releases a novel small messenger that stimulates Ca2+ influx. Nature. 1993;364:809-818. [Medline] [Order article via Infotrieve]
38.
Nishimura J, Kolber M, van Breemen C. Norepinephrine and
GTP-gamma-S increase myofilament Ca2+ sensitivity in
-toxin permeabilized arterial smooth muscle. Biochem Biophys
Res Commun. 1988;157:677-683. [Medline]
[Order article via Infotrieve]
39.
Kitazawa T, Kobayashi S, Horiuti K, Somlyo AV, Somlyo AP.
Receptor-coupled, permeabilized smooth muscle. J Biol Chem. 1989;264:5339-5342.
40.
Heagerty AM, Aalkjaer C, Bund SJ, Korsgaard N, Mulvany MJ.
Small artery structure in hypertension: dual processes of remodeling
and growth. Hypertension. 1993;21:391-397.
This article has been cited by other articles:
![]() |
R. Miquel, R. Gisbert, E. Serna, F. Perez-Vizcaino, E. Anselmi, M. A. Noguera, M. D. Ivorra, and M. P. D'Ocon Acute and Chronic Captopril, but Not Prazosin or Nifedipine, Normalize Alterations in Adrenergic Intracellular Ca2+ Handling Observed in the Mesenteric Arterial Tree of Spontaneously Hypertensive Rats J. Pharmacol. Exp. Ther., April 1, 2005; 313(1): 359 - 367. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Seko, M. Ito, Y. Kureishi, R. Okamoto, N. Moriki, K. Onishi, N. Isaka, D. J. Hartshorne, and T. Nakano Activation of RhoA and Inhibition of Myosin Phosphatase as Important Components in Hypertension in Vascular Smooth Muscle Circ. Res., March 7, 2003; 92(4): 411 - 418. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Ungvari and A. Koller Endothelin and Prostaglandin H2/Thromboxane A2 Enhance Myogenic Constriction in Hypertension by Increasing Ca2+ Sensitivity of Arteriolar Smooth Muscle Hypertension, November 1, 2000; 36(5): 856 - 861. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Mupanomunda, Y. Wang, and R. D. Bukoski Effect of chronic sensory denervation on Ca2+-induced relaxation of isolated mesenteric resistance arteries Am J Physiol Heart Circ Physiol, May 1, 1998; 274(5): H1655 - H1661. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-B. Roullet, U. C. Luft, H. Xue, J. Chapman, R. Bychkov, C. M. Roullet, F. C. Luft, H. Haller, and D. A. McCarron Farnesol Inhibits L-type Ca2+ Channels in Vascular Smooth Muscle Cells J. Biol. Chem., December 19, 1997; 272(51): 32240 - 32246. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. D. Bukoski, K. Bian, Y. Wang, and M. Mupanomunda Perivascular Sensory Nerve Ca2+ Receptor and Ca2+-Induced Relaxation of Isolated Arteries Hypertension, December 1, 1997; 30(6): 1431 - 1439. [Abstract] [Full Text] |
||||
![]() |
L. M. Shaw, J. Ohanian, and A. M. Heagerty Calcium Sensitivity and Agonist-Induced Calcium Sensitization in Small Arteries of Young and Adult Spontaneously Hypertensive Rats Hypertension, September 1, 1997; 30(3): 442 - 448. [Abstract] [Full Text] |
||||
![]() |
R. J. Baines, C. Brown, L. L. Ng, and M. R. Boarder Angiotensin II–Stimulated Phospholipase C Responses of Two Vascular Smooth Muscle–Derived Cell Lines: Role of Cyclic GMP Hypertension, November 1, 1996; 28(5): 772 - 778. [Abstract] [Full Text] |
||||
![]() |
A. S. Izzard, S. J. Bund, and A. M. Heagerty Increased Wall-Lumen Ratio of Mesenteric Vessels From the Spontaneously Hypertensive Rat Is Not Associated With Increased Contractility Under Isobaric Conditions Hypertension, October 1, 1996; 28(4): 604 - 608. [Abstract] [Full Text] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1995 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |